Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1975-07-21
1977-05-17
Meyers, Albert T.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23253TP, 424 8, 424 12, 424 86, 424 89, 424 93, A61K 3912, A61K 4300, G01N 3122, G01N 3316
Patent
active
040242358
ABSTRACT:
Method of detecting and/or quantitating anti-virus antibodies comprising the steps of reacting serum containing an unknown amount of a given antibody, a known amount of the antibody (radioactively labelled), and a composite consisting of the antibodies coupled chemically through an intermediate silane coupling agent to a porous glass body, the composite having complexed thereto quantities of the virus; separating the composite from the reaction solution after a suitable reaction period; determining the radioactivity count of the separated composite or the remaining solution; and, relating the count to a standard curve.
REFERENCES:
patent: 3652761 (1972-03-01), Weetall
Weetall Howard H.
Yaverbaum Sidney
Corning Glass Works
Fagelson A. P.
Giblin James A.
Janes Jr. Clinton S.
Meyers Albert T.
LandOfFree
Detection and quantitation of viral antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection and quantitation of viral antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection and quantitation of viral antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1834877